ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves HPV Test

April 25, 2003

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

August 2, 1996

ONS Congress Plans, Certification Exams Set For Pittsburgh

October 30, 1987

Obama Lifts Ban on Federal Funding for Embryonic Stem Cell Research, Signs Memo on Scientific Integrity

March 13, 2009

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999